TrialCancer2013

A prospective, phase 1/2 study of everolimus and temozolomide in patients with advanced pancreatic neuroendocrine tumor.

Jennifer A Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.